Leukemic Environment Alters Neutrophils Worsening Disease Progression

نویسندگان

چکیده

Abstract Acute Myeloid Leukemia (AML) is the abnormal differentiation of hematopoietic stem cells in bone marrow into malignant blasts. The leukemic environment plays an important role during disease progression, by shaping immune landscape interacting with these Mounting evidence suggests neutrophils are complicit within tumors enhancing tumorigenesis and immunosuppression; however, little known about how contribute to AML even though comprise half cellularity. Tumor-associated found overactivated state, constantly releasing pro-inflammatory cytokines granular proteins promote tumorigenesis. Therefore, we investigated neutrophil phenotype our chimeric mouse model. We observed were also activated state. More importantly, sorted leukemic-exposed more susceptible degranulation upon stimulation. Next, single-cell RNA data showed that had higher expression ELANE, a gene encoding elastase (NE). Increased NE levels have been associated increased tumor burden many cancers. Although increase inflammation which drives tumorigenesis, it may directly blast proliferation. By targeting model using anti-Ly6G antibody, decreased frequency blasts depleted mice. Also, there was reduced Lin-ckit +CD16/32 +leukemic cells. hypothesize over-activated drive progression BM NE, providing new avenue for intervention.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Rab11 in Disease Progression

Membrane/ protein trafficking in the secretory/ biosynthetic and endocytic pathways is mediated by vesicles. Vesicle trafficking in eukaryotes is regulated by a class of small monomeric GTPases the Rab protein family. Rab proteins represent the largest branch of the Ras superfamily GTPases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular sig...

متن کامل

Glycosaminoglycans in Human Neutrophils and Leukemic

Chondroitin sulfate is known to be present in normal and leukemic myeloid cells; however. its definitive subcellular location and association with other glycosaminoglycans (GAGs) has not been demonstrated. We have studied the type and distribution of GAGs in neutrophil granule subpopulations of normal and leukemic myeloid cells using ultrastructural. cytochemical. immunologic. and biochemical m...

متن کامل

Cellular Transplantation Alters the Disease Progression in Becker's Muscular Dystrophy

Becker's Muscular Dystrophy (BMD) is a dystrophinopathy manifested as progressive muscle degeneration. Autologous Bone Marrow Mononuclear Cells (BMMNCs) have shown some myogenic potential. The paracrine effects of the BMMNCs reduce the inflammation and are thought to reduce muscle degeneration. We treated a 39 year old dental surgeon suffering from BMD. Muscle strength was reduced when measured...

متن کامل

rab11 in disease progression

membrane/ protein trafficking in the secretory/ biosynthetic and endocytic pathways is mediated by vesicles. vesicle trafficking in eukaryotes is regulated by a class of small monomeric gtpases the rab protein family. rab proteins represent the largest branch of the ras superfamily gtpases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular sig...

متن کامل

Glycosaminoglycans in Human Neutrophils and Leukemic Myeloblasts : Ultrastructural ,

Chondroitin sulfate is known to be present in normal and leukemic myeloid cells; however. its definitive subcellular location and association with other glycosaminoglycans (GAGs) has not been demonstrated. We have studied the type and distribution of GAGs in neutrophil granule subpopulations of normal and leukemic myeloid cells using ultrastructural. cytochemical. immunologic. and biochemical m...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Immunology

سال: 2023

ISSN: ['1550-6606', '0022-1767']

DOI: https://doi.org/10.4049/jimmunol.210.supp.84.07